# Boulevard Bio

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/boulevard-bio

- Industry: Biotechnology
- Headquarters: New York, US
- Website: www.boulevardbio.com
- Latest round: Seed (Aug 12, 2026)
- Investors on record: 1

## About

Based in the New York, US, and founded in 2021, Boulevard Bio, Inc. research and develop antibody therapies for B cell-driven autoimmune diseases and other immune-related conditions.

## Funding rounds

- Seed, Aug 12, 2026 — Deerfield Management

## Investors

- Deerfield Management (https://capitalatlas.ai/funds/deerfield-management) — Seed